May 29—HYANNIS — Cape Cod Hospital this week became one of the first hospitals in the country to host a mobile infusion center to treat newly diagnosed COVID-19 patients with Regeneron.
Known as a monoclonal antibody treatment, Regeneron was first approved by the Food and Drug Administration in November and is designed to keep those at higher risk of severe illness from COVID-19 from being hospitalized.
“This is the first one in the country that’s mobile. We’re a test case,” said Dr. Kevin Mulroy, chief quality officer for Cape Cod Healthcare, the parent company of Cape Cod Hospital.
The mobile unit operated by Anyplace M.D. of Austin, Texas, is parked near the COVID-19 testing tent on the hospital campus in Hyannis.
It looks like a big RV or bloodmobile but provides patients with infusions of clear liquid Regeneron, which was among the treatments former President Donald Trump received when he